These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34055625)

  • 1. Ancient Adversary - HERV-K (HML-2) in Cancer.
    Dervan E; Bhattacharyya DD; McAuliffe JD; Khan FH; Glynn SA
    Front Oncol; 2021; 11():658489. PubMed ID: 34055625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
    George M; Schwecke T; Beimforde N; Hohn O; Chudak C; Zimmermann A; Kurth R; Naumann D; Bannert N
    Retrovirology; 2011 May; 8():30. PubMed ID: 21554716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Infection of Primary CD4
    Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant origin and interspecies transmission of a HERV-K(HML-2)-related primate retrovirus with a novel RNA transport element.
    Williams ZH; Imedio AD; Gaucherand L; Lee DC; Mostafa SM; Phelan JP; Coffin JM; Johnson WE
    Elife; 2024 Jul; 13():. PubMed ID: 39037763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing.
    Xue B; Zeng T; Jia L; Yang D; Lin SL; Sechi LA; Kelvin DJ
    Retrovirology; 2020 May; 17(1):10. PubMed ID: 32375827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Endogenous Retrovirus K (HML-2) in Health and Disease.
    Xue B; Sechi LA; Kelvin DJ
    Front Microbiol; 2020; 11():1690. PubMed ID: 32765477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response.
    Russ E; Mikhalkevich N; Iordanskiy S
    Microbiol Spectr; 2023 Mar; 11(2):e0443822. PubMed ID: 36861980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues.
    Schmitt K; Heyne K; Roemer K; Meese E; Mayer J
    Mob DNA; 2015; 6():4. PubMed ID: 25750667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterising a human endogenous retrovirus(HERV)-derived tumour-associated antigen: enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines.
    Tatkiewicz W; Dickie J; Bedford F; Jones A; Atkin M; Kiernan M; Maze EA; Agit B; Farnham G; Kanapin A; Belshaw R
    Mob DNA; 2020; 11():9. PubMed ID: 32055257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Endogenous Retrovirus-K (HML-2)-Related Genetic Variation: Human Genome Diversity and Disease.
    Shin W; Mun S; Han K
    Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human endogenous retrovirus encoded protease potentially cleaves numerous cellular proteins.
    Rigogliuso G; Biniossek ML; Goodier JL; Mayer B; Pereira GC; Schilling O; Meese E; Mayer J
    Mob DNA; 2019; 10():36. PubMed ID: 31462935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
    Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
    Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.
    Ehlhardt S; Seifert M; Schneider J; Ojak A; Zang KD; Mehraein Y
    J Rheumatol; 2006 Jan; 33(1):16-23. PubMed ID: 16395745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients.
    Weber M; Padmanabhan Nair V; Bauer T; Sprinzl MF; Protzer U; Vincendeau M
    Cells; 2021 Mar; 10(4):. PubMed ID: 33807462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma.
    Ma W; Hong Z; Liu H; Chen X; Ding L; Liu Z; Zhou F; Yuan Y
    Biomed Res Int; 2016; 2016():8201642. PubMed ID: 28070518
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination.
    Flockerzi A; Maydt J; Frank O; Ruggieri A; Maldener E; Seifarth W; Medstrand P; Lengauer T; Meyerhans A; Leib-Mösch C; Meese E; Mayer J
    Retrovirology; 2007 Jun; 4():39. PubMed ID: 17550625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.
    Hohn O; Hanke K; Bannert N
    Front Oncol; 2013 Sep; 3():246. PubMed ID: 24066280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of HERV in human cells: expression and coding capacity of human proviruses.
    Mayer J
    Dev Biol (Basel); 2001; 106():439-41; discussion 465-75. PubMed ID: 11761259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.
    Dembny P; Newman AG; Singh M; Hinz M; Szczepek M; Krüger C; Adalbert R; Dzaye O; Trimbuch T; Wallach T; Kleinau G; Derkow K; Richard BC; Schipke C; Scheidereit C; Stachelscheid H; Golenbock D; Peters O; Coleman M; Heppner FL; Scheerer P; Tarabykin V; Ruprecht K; Izsvák Z; Mayer J; Lehnardt S
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.